Univercells Technologies Launches Miniaturized scale-X™ Nexo Bioreactor to Accelerate Cell Culture Process Development

Univercells Technologies by Donaldson, a global leader in bioprocessing technologies, proudly announces the launch of it...

October 17, 2024 | Thursday | News
NUS Enterprise staged Asia’s largest university start-up showcase in Singapore

Themed "Driving Innovation, Nurturing Talents: Creating Impact for Asia", InnovFest x Elevating Founders 2024&nbs...

May 30, 2024 | Thursday | Company results
Singapore evaluates 'Innovation Enhancing Techniques' (IETs) to tackle healthcare-biomedicine R&D and entrepreneurship barriers

Researchers from Singapore's Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and the Un...

January 15, 2024 | Monday | Analysis
Enterprise Singapore & A*STAR upholds Singapore's promising biomedical companies at JPM 2024 Conference

The 42nd Annual Healthcare Conference was held on January 8-11, 2024 in San Francisco, CA. Global industry leaders, fast...

January 12, 2024 | Friday | News
EY Center for Sustainable Supply Chains launches in Singapore

The EY, has launched new EY Center for Sustainable Supply Chains in Singapore. The Center is dedicated to...

August 22, 2023 | Tuesday | Company results
ASEAN Businesses to get funding for mediating IP or technology disputes

  Businesses in the Association of Southeast Asian Nations (ASEAN) can now benefit from subsidised mediation ...

July 3, 2023 | Monday | Regulatory
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist

Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...

September 28, 2022 | Wednesday | News
Florence Vicaire joins Univercells Technologies as CCO

“This appointment reflects our commitment to strategic development and expansion within the gene therapy market. W...

September 1, 2022 | Thursday | News
VNU Exhibitions Asia Pacific kicks off busy second half of the year 2022

Being in its 10th year in Thailand’s exhibition market, VNU Exhibitions Asia Pacific is looking for an eventful 20...

July 6, 2022 | Wednesday | News
DIA CoRE Singapore Annual Meeting 2022 set to discuss regulatory frameworks and drug development

DIA CoRE Singapore Annual Meeting 2022 is set to unravel from 12-13 July 2022 on account of the 5th-year anniversary. Th...

June 15, 2022 | Wednesday | News
Korea gears up for global stand in bio-health business

Korea is setting its platform to kick start BIO KOREA, the biggest bio-health convention in Asia to uphol...

April 7, 2022 | Thursday | News
Wisdom announces Global Biocontrol Summit (3rd Edition)

  The 3rd edition of Wisdom’s acclaimed Global Biocontrol Summit will be held on 11 – 12 May 2022, vir...

March 18, 2022 | Friday | News
TechInnovation 2021: Collaboration, Innovation, and Sustainability at entrepreneurship

  TechInnovation 2021, IPI’s flagship technology matching event, was held as a fully digital ...

September 30, 2021 | Thursday | Company results
Japan's TANAKA holdings encourage overseas medical startups by investment opportunities

TANAKA Kikinzoku Kogyo K.K. which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals m...

September 9, 2021 | Thursday | News
CBC-led firms pick 46.9% equity interest in Korea's largest medical aesthetics company

A consortium led by CBC Group has signed a definitive agreement to acquire a 46.9% equity interest in Hugel, Inc. f...

August 25, 2021 | Wednesday | News
FCGF explores post-COVID opportunities through ASEAN-China collaboration

The FutureChina Global Forum (FCGF) 2021, organised by Business China, a non-profit organization that aims to strengthen...

July 12, 2021 | Monday | News
Largest private fundraising round by Asia-based life sciences firm

Singapore-based Esco Lifesciences has announced the close of an over-subscribed $200 million Series A and Cros...

May 27, 2021 | Thursday | News
London based Bioventures finance/manages late-stage phase III developments

London-based Bioventures Abingworth finance/manages late-stage phase III developments. It has announced the final clos...

May 11, 2021 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls